recentpopularlog in

jerryking : chemicals   7

Can we just relax about our breasts? - The Globe and Mail

The Globe and Mail

Last updated Wednesday, Oct. 31 2012

the real problem isn’t jet fuel in our breasts. It’s chemophobia – a fear so rampant that it has infected an entire generation of women. Ms. Williams is right that our bodies contain trace amounts of pretty much everything that’s in our environment. But toxicity is a matter of degree. And technology is so advanced that we can measure trace amounts in parts per trillion. As yet, research has found no trace of harm. For example, after a comprehensive review of environmental causes and risk factors for breast cancer, the U.S. Institute of Medicine found no conclusive link between any of these chemicals and an increased risk of breast cancer. According to Scientific American, “some research shows the toxic load in breast milk to be smaller than that in the air most city dwellers breathe inside their homes.”

So what are the biggest risks for breast cancer? Getting old, and being female. “If you parse out all the things that cause breast cancer, about 75 per cent of it is living,” Harvey Schipper, one of Canada’s leading breast cancer doctors, told me. Much of the rest is hereditary. Other risk factors are bound up with our Western lifestyle – high-protein diets, early puberty, later and less frequent childbearing. “Societies with poor nutrition don’t get breast cancer,” he says.

This is not to say there’s no impact from environmental factors. But these effects are small and uncertain. To eliminate them all, we’d have to eliminate modernity and return to being hunter-gatherers again.

But I’m afraid chemophobia is here to stay. Fear sells. Fear of chemicals manufactured by rapacious, greedy, money-sucking capitalist enterprises sells even better.
ageing  cancers  chemicals  fear  hunter-gatherers  Margaret_Wente  medical_communication  rapaciousness  risk_factors  toxicity 
february 2013 by jerryking
Private Investors Shift Focus to Continent - Google Drive
Feb. 9, 2004 | Chemical market Reporter | Anonymous.

Private equity investors' focus is shifting from the UK, where some private equity specialists predict increased acquisition activity in chemicals this year, to continental Europe, especially Germany and France. The European chemicals sector, which currently has an estimated $12 billion of assets on offer, is increasingly attractive to private equity companies owing to continued consolidation and restructuring by global producers, as well as stronger competitive pressure from Asia.
private_equity  chemicals  Europe 
january 2013 by jerryking
Not Business As Usual

Veteran consultant Peter Spit2‘s new book, The Chemical lndustry at the Mi||ennium­Maturìty, Restructuring, and Globalization, was published in December. Because Spitz and his five co-authors--all of whom have invested their careers inthe chemical industry--bring a long and deep perspective on the industry's journey in the last 20 years. The book provides a valuable narrative of chemical industry developments, a worthy companion to his earlier book Petrochemicals: Birth of an lndustry. But the volume also provides useful pointers on likely future developments. lts broad scope-ranging from specialties to globalization, from Wall Street to environmental concerns, from lT and ecommerce to the growing role of hydrocarbon-rich producing countries-tends to result in any prescriptions being general, but speciñc lessons can be drawn from a careful read.
chemicals  industries  books  mature_industries 
january 2013 by jerryking
Private equity looks to differentiate
November 21-December 4, 2005 | Chemical Market Reporter | Joseph Chang.

WHILE PRIVATE-EQUlTY will always seek to buy assets cheaply and sell them at high prices, the role of private equity is changing. Larger and more players are entering the game, and as competition increases, financial buyers must differentiate their strategy to create value.
"About 60 percent of the value from private­equity deals cornes from buying low and selling high." said Timothy Walsh. partner at JPMorgan Partners, at the Competitive Chemical Enterprise Conference held in New York last week. "The other 40 percent-improving the business­is becoming much more important."
JPMorgan Partners looks for speciality businesses that are on the verge of commoditization, where it can improve operations.
"We in private equity are price takers-so how do we create a return?" asked Walsh. ln the case of silicas firm PQ Corp. JPMorgan Partners brought in an experienced management team and enhanced focus on cost structure and processes.
Over the past few years, private-equity funds have gained in size and number. The number of funds over S1 billion
has grown from just five in 1989 and eight in 1994 to 97 today, Walsh noted. "The numbers and size will continue to grow," he added.
private_equity  chemicals  differentiation  commoditization  specialists  specialization  value_creation  financial_buyers 
january 2013 by jerryking
Strategies for the Chemical Industry: How to Create a World of Opportunities
March 01, 2006 | Chemical Equipment | Anonymous. Few would
deny that opportunities exist in chemicals, but prevailing wisdom
suggests that the chemical industry is a mature sector. Maturity,
though, lies in the eye of the beholder. Large parts of the sector are
solid, plodding even, but they produce decent returns and could produce
more. Exciting areas of research are opening up new products as well
as product application frontiers. The industry has weathered stock
market storms fairly successfully over the past 25 years and there is
little to suggest that it will not remain robust. That’s the view of
Florian Budde, Heiner Frankemolle and Utz-Hellmuth Felcht, editors of
the just updated book “Value Creation: Strategies for the Chemical
chemicals  howto  book_reviews  strategic_planning  opportunities  investments  value_creation  new_products  mature_industries 
december 2010 by jerryking
A steady fight back from spectacular collapse
Mar 19, 2007 | Financial Times pg. 4 | DELPHINE STRAUSS
Rhodia, the speciality chemicals group, has returned from the brink.
Arkema, another French chemicals group, has begun a parallel recovery;
Rhodia  Arkema  turnarounds  chemicals 
june 2009 by jerryking

Copy this bookmark:

to read